Nantkwest / Immunitybio -> IBRX WKN: A2QQ2E ISIN: US45256X1037 Forum: Aktien User: captainpump97

https://x.com/actionfixesfear/status/2056971079504306571?s=46

Ich meine… wenn es keine Hintertür gibt, kann man auch direkt approven oder 😅

Klingt halt als wenn man sich eine Hintertür offen lässt. Auch das hier : The Agency further provided insight as to the focus of the review of this sBLA by stating, “The scientific data detailing these overlapping features will be the focus of the review of this sBLA to determine if there is adequate justification to allow for such an extrapolation and expansion of the indication of Anktiva with BCG to include the treatment of patients with BCG-unresponsive NMIBC with papillary tumors,”

Klingt halt als wenn man sich eine Hintertür offen lässt. Auch das hier : The Agency further provided insight as to the focus of the review of this sBLA by stating, “The scientific data detailing these overlapping features will be the focus of the review of this sBLA to determine if there is adequate justification to allow for such an extrapolation and expansion of the indication of Anktiva with BCG to include the treatment of patients with BCG-unresponsive NMIBC with papillary tumors,”